ID

25172

Descripción

Tysabri Observational Program; ODM derived from: https://clinicaltrials.gov/show/NCT00493298

Link

https://clinicaltrials.gov/show/NCT00493298

Palabras clave

Versiones (1)
  1. 28/8/17 28/8/17 -
Subido en

28 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

Inglés

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

1 formularios  
Criteria
Descripción

Criteria

documented diagnosis of relapsing remitting multiple sclerosis
Descripción

Multiple Sclerosis, Relapsing-Remitting

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0751967
the decision to treat with tysabri must precede enrollment
Descripción

Tysabri

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1529600
patient must be a new tysabri user, and must not have had more than 3 tysabri infusions prior to enrollment
Descripción

Tysabri Use of Firstly | Tysabri Infusion Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1529600
UMLS CUI [1,2]
C1524063
UMLS CUI [1,3]
C1279901
UMLS CUI [2,1]
C1529600
UMLS CUI [2,2]
C0574032
UMLS CUI [2,3]
C1265611
must have had at least one relapse in the previous year, and must satisfy locally approved therapeutic indications for tysabri
Descripción

Relapse Quantity | Indication Tysabri

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C1529600
key exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
history of progressive multifocal leukoencephalopathy or other opportunistic infections, or an increased risk of opportunistic infections
Descripción

Leukoencephalopathy, Progressive Multifocal | Opportunistic Infections | Opportunistic Infections Risk Increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023524
UMLS CUI [2]
C0029118
UMLS CUI [3,1]
C0029118
UMLS CUI [3,2]
C0035647
UMLS CUI [3,3]
C0205217
history of positive anti-natalizumab antibodies
Descripción

Natalizumab Ab Positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1977362
UMLS CUI [1,2]
C1514241
concomitant immunomodulatory or immunosuppressive therapy during therapy with tysabri
Descripción

Immunomodulation | Therapeutic immunosuppression | Tysabri

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1963758
UMLS CUI [2]
C0021079
UMLS CUI [3]
C1529600
patient immunocompromised at the time of enrollment
Descripción

Patient Immunocompromised

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0085393
known active malignancy
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
women must not be breast feeding or pregnant, or planning to become pregnant (must use birth control unless surgically sterile)
Descripción

Breast Feeding | Pregnancy | Pregnancy, Planned | Gender Contraceptive methods | Exception Female Sterilization

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0700589
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0015787
note: other protocol defined inclusion/exclusion criteria may apply.
Descripción

Clinical Trial Eligibility Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Multiple Sclerosis, Relapsing-Remitting
Item
documented diagnosis of relapsing remitting multiple sclerosis
boolean
C0751967 (UMLS CUI [1])
Tysabri
Item
the decision to treat with tysabri must precede enrollment
boolean
C1529600 (UMLS CUI [1])
Tysabri Use of Firstly | Tysabri Infusion Quantity
Item
patient must be a new tysabri user, and must not have had more than 3 tysabri infusions prior to enrollment
boolean
C1529600 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C1279901 (UMLS CUI [1,3])
C1529600 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Relapse Quantity | Indication Tysabri
Item
must have had at least one relapse in the previous year, and must satisfy locally approved therapeutic indications for tysabri
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1529600 (UMLS CUI [2,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Leukoencephalopathy, Progressive Multifocal | Opportunistic Infections | Opportunistic Infections Risk Increased
Item
history of progressive multifocal leukoencephalopathy or other opportunistic infections, or an increased risk of opportunistic infections
boolean
C0023524 (UMLS CUI [1])
C0029118 (UMLS CUI [2])
C0029118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205217 (UMLS CUI [3,3])
Natalizumab Ab Positive
Item
history of positive anti-natalizumab antibodies
boolean
C1977362 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
Immunomodulation | Therapeutic immunosuppression | Tysabri
Item
concomitant immunomodulatory or immunosuppressive therapy during therapy with tysabri
boolean
C1963758 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C1529600 (UMLS CUI [3])
Patient Immunocompromised
Item
patient immunocompromised at the time of enrollment
boolean
C0030705 (UMLS CUI [1,1])
C0085393 (UMLS CUI [1,2])
Malignant Neoplasms
Item
known active malignancy
boolean
C0006826 (UMLS CUI [1])
Breast Feeding | Pregnancy | Pregnancy, Planned | Gender Contraceptive methods | Exception Female Sterilization
Item
women must not be breast feeding or pregnant, or planning to become pregnant (must use birth control unless surgically sterile)
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0015787 (UMLS CUI [5,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
note: other protocol defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial